Worldwide: Consumer Protection

Subscribe
Consumer protection law thought leadership, articles, podcasts, videos and webinars from expert sources across the legal world. Explore insights covering topics that involve consumer protection regulations and the developing law surrounding them from specialists working in this area.
Article
New Jersey Supreme Court Strengthens Expert Gatekeeping In Product Liability Cases: What Beavan v. Allergan Means For Defendants
In product liability litigation, the straightest path to a favorable outcome for the defense is disqualification of the plaintiff’s expert. In a unanimous decision, New Jersey’s Supreme Court in Beavan v. Allergan U.S.A., Inc., A-53-24 (N.J. May 27, 2026), has substantially bolstered the defense position in that critical fight.
United States Consumer
WE
Wilson Elser Moskowitz Edelman & Dicker LLP
Article
New York Takes Aim At Self-GRAS: Mandatory Disclosure Law Poised To Reshape Food Ingredient Oversight
On April 21, 2026, the New York Assembly passed the Food Safety and Chemical Disclosure Act legislation that would establish a first-of-its-kind reporting regime for substances deemed “generally recognized as safe” (GRAS). While state laws have long prohibited the sale of adulterated or misbranded food, they have not required companies to submit GRAS determinations or otherwise disclose the basis for those conclusions at the state level.
United States Consumer
AP
Arnold & Porter
See more
See more
See more
Article
New Jersey Supreme Court Strengthens Expert Gatekeeping In Product Liability Cases: What Beavan v. Allergan Means For Defendants
In product liability litigation, the straightest path to a favorable outcome for the defense is disqualification of the plaintiff’s expert. In a unanimous decision, New Jersey’s Supreme Court in Beavan v. Allergan U.S.A., Inc., A-53-24 (N.J. May 27, 2026), has substantially bolstered the defense position in that critical fight.
United States Consumer
WE
Wilson Elser Moskowitz Edelman & Dicker LLP
Article
Sixth Circuit Shuts The Door On “Trial By Formula” And “Mini Trials” In Reversing Class Certification
This monthly newsletter examines pivotal developments in product liability and mass tort litigation, including the Sixth Circuit's landmark reversal of class certification that rejected formulaic damages models, FDA's dual approach to AI regulation in pharmaceutical manufacturing and clinical trials, and the Supreme Court's expansive interpretation of federal officer removal jurisdiction.
United States Litigation
D
Dechert
See more
See more